2021 Vol.39, N°5 - Suppl.132 - Table of contents
Behçet's Disease and other Autoinflammatory Conditions - no. 21
21st Annual Supplement on Behçet's Disease and other Autoinflammatory Conditions
Guest Editors: H. Yazici, E. Ben-Chetrit
One year in review
CER14823
2021,39,5,Suppl.132
Pg. 0003-0013
Free to view
One year in review 2021: Behçet's syndrome
G. Hatemi, E. Seyahi, I. Fresko, R. Talarico, D. Uçar, V. Hamuryudan
DOI: https://doi.org/10.55563/clinexprheumatol/lnvc9k
G. Hatemi, E. Seyahi, I. Fresko, R. Talarico, D. Uçar, V. Hamuryudan
DOI: https://doi.org/10.55563/clinexprheumatol/lnvc9k
Editorial
CER15077
2021,39,5,Suppl.132
Pg. 0014-0017
Free to view
How to classify PFAPA? No hard evidence for associated CAPS or CARD variants and not any for links with Behçet’s syndrome
E. Ben-Chetrit, H. Yazici
DOI: https://doi.org/10.55563/clinexprheumatol/x453f7
E. Ben-Chetrit, H. Yazici
DOI: https://doi.org/10.55563/clinexprheumatol/x453f7
Full Papers
CER14175
2021,39,5,Suppl.132
Pg. 0018-0021
Free to view
Association between serum amyloid A1 genotype and age of onset restricts to M694 homozygote familial Mediterranean fever patients in Armenia
G. Kriegshäuser, H. Hayrapetyan, S. Atoyan, C. Oberkanins, T. Sarkisian
DOI: https://doi.org/10.55563/clinexprheumatol/hvktbk
G. Kriegshäuser, H. Hayrapetyan, S. Atoyan, C. Oberkanins, T. Sarkisian
DOI: https://doi.org/10.55563/clinexprheumatol/hvktbk
CER13990
2021,39,5,Suppl.132
Pg. 0022-0029
Free to view
Dual effects of interleukin-10 on natural killer cells and monocytes and the implications for adult-onset Still’s disease
Y. Aizaki, H. Yazawa, K. Sato, T. Mimura
DOI: https://doi.org/10.55563/clinexprheumatol/2vdem0
Y. Aizaki, H. Yazawa, K. Sato, T. Mimura
DOI: https://doi.org/10.55563/clinexprheumatol/2vdem0
CER14343
2021,39,5,Suppl.132
Pg. 0030-0036
Free to view
Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients
N. Atas, G.A. Eroglu, H.N. Sodan, B.O. Ozturk, H. Babaoglu, H. Satis, H. Karadeniz, A.A. Guler, R.B. Salman, B. Goker, M.A. Ozturk, S. Haznedaroglu, A. Tufan
DOI: https://doi.org/10.55563/clinexprheumatol/815tdt
N. Atas, G.A. Eroglu, H.N. Sodan, B.O. Ozturk, H. Babaoglu, H. Satis, H. Karadeniz, A.A. Guler, R.B. Salman, B. Goker, M.A. Ozturk, S. Haznedaroglu, A. Tufan
DOI: https://doi.org/10.55563/clinexprheumatol/815tdt
CER14153
2021,39,5,Suppl.132
Pg. 0037-0042
Free to view
Tocilizumab in Behçet’s disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes
B. Atienza-Mateo, E. Beltrán, M. Hernández-Garfella, E. Valls Pascual, L. Martínez-Costa, A. Atanes, C. Moriano, M. Cordero-Coma, J.M. Nolla, C. Carrasco Cubero, J. Sánchez Martín, V. Calvo-Río, R. Demetrio, N. Palmou-Fontana, M.Á. González-Gay, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/9ipkcs
B. Atienza-Mateo, E. Beltrán, M. Hernández-Garfella, E. Valls Pascual, L. Martínez-Costa, A. Atanes, C. Moriano, M. Cordero-Coma, J.M. Nolla, C. Carrasco Cubero, J. Sánchez Martín, V. Calvo-Río, R. Demetrio, N. Palmou-Fontana, M.Á. González-Gay, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/9ipkcs
CER13795
2021,39,5,Suppl.132
Pg. 0043-0046
Free to view
Initial visit symptoms in probable Behçet's syndrome is predictive of ISG criteria fulfillment in Behçet's syndrome: data from New York and Amsterdam cohorts
F.G. Kerstens, F. Turkstra, C.J. Swearingen, Y. Yazici
DOI: https://doi.org/10.55563/clinexprheumatol/0hia54
F.G. Kerstens, F. Turkstra, C.J. Swearingen, Y. Yazici
DOI: https://doi.org/10.55563/clinexprheumatol/0hia54
CER14564
2021,39,5,Suppl.132
Pg. 0047-0050
Free to view
Prevalence and clinical course of SARS-CoV-2 infection in patients with Behçet’s syndrome
I. Mattioli, A. Bettiol, E. Silvestri, M.L. Urban, A. Palermo, F. Fagni, D. Malandrino, A. Del Bianco, D. Prisco, G. Emmi
DOI: https://doi.org/10.55563/clinexprheumatol/pmnqmf
I. Mattioli, A. Bettiol, E. Silvestri, M.L. Urban, A. Palermo, F. Fagni, D. Malandrino, A. Del Bianco, D. Prisco, G. Emmi
DOI: https://doi.org/10.55563/clinexprheumatol/pmnqmf
CER14261
2021,39,5,Suppl.132
Pg. 0051-0058
Free to view
Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial
H.J. Lachmann, B. Lauwerys, P. Miettunen, T. Kallinich, A. Jansson, I. Rosner, R. Manna, S. Murias, S. Savic, S. Smeets, F. De Benedetti, A. Simon
DOI: https://doi.org/10.55563/clinexprheumatol/e92f7o
H.J. Lachmann, B. Lauwerys, P. Miettunen, T. Kallinich, A. Jansson, I. Rosner, R. Manna, S. Murias, S. Savic, S. Smeets, F. De Benedetti, A. Simon
DOI: https://doi.org/10.55563/clinexprheumatol/e92f7o
CER14541
2021,39,5,Suppl.132
Pg. 0059-0066
Free to view
Clinical characteristics of macrophage activation syndrome in adult-onset Still’s disease
Q. Gao, Y. Yuan, Y. Wang, J. Jiang, Z. Ye, T. Liu, Z. Jiang, L. Zhao
DOI: https://doi.org/10.55563/clinexprheumatol/lp2u7g
Q. Gao, Y. Yuan, Y. Wang, J. Jiang, Z. Ye, T. Liu, Z. Jiang, L. Zhao
DOI: https://doi.org/10.55563/clinexprheumatol/lp2u7g
CER14664
2021,39,5,Suppl.132
Pg. 0067-0074
Free to view
Expression signature of inflammation-associated long non-coding RNAs in adult-onset Still’s disease
C.-A. Yang, P.-K. Chen, J.-L. Lan, C.-K. Chang, J.-G. Chang, S.-H. Chang, C.-C. Lin, D.-Y. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/4jx6zy
C.-A. Yang, P.-K. Chen, J.-L. Lan, C.-K. Chang, J.-G. Chang, S.-H. Chang, C.-C. Lin, D.-Y. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/4jx6zy
CER14733
2021,39,5,Suppl.132
Pg. 0075-0079
Free to view
Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab
A. Druyan, E. Giat, A. Livneh, C. Grossman, I. Ben-Zvi, M. Lidar
DOI: https://doi.org/10.55563/clinexprheumatol/rrr9zd
A. Druyan, E. Giat, A. Livneh, C. Grossman, I. Ben-Zvi, M. Lidar
DOI: https://doi.org/10.55563/clinexprheumatol/rrr9zd
CER14837
2021,39,5,Suppl.132
Pg. 0080-0087
Free to view
Apremilast for oral ulcers associated with active Behçet’s syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial
G. Hatemi, A. Mahr, M. Takeno, D.Y. Kim, D. Saadoun, H. Direskeneli, M. Melikoğlu, S. Cheng, S. Mccue, M. Paris, M. Chen, Y. Yazici
DOI: https://doi.org/10.55563/clinexprheumatol/ra8ize
G. Hatemi, A. Mahr, M. Takeno, D.Y. Kim, D. Saadoun, H. Direskeneli, M. Melikoğlu, S. Cheng, S. Mccue, M. Paris, M. Chen, Y. Yazici
DOI: https://doi.org/10.55563/clinexprheumatol/ra8ize
CER15039
2021,39,5,Suppl.132
Pg. 0088-0093
Free to view
Adherence to treatment in Behçet’s syndrome: a multi-faceted issue
S. Pirri, D. Marinello, V. Lorenzoni, G. Andreozzi, A. Bazzani, A. Del Bianco, G. Turchetti, M. Mosca, R. Talarico
DOI: https://doi.org/10.55563/clinexprheumatol/1lx7a5
S. Pirri, D. Marinello, V. Lorenzoni, G. Andreozzi, A. Bazzani, A. Del Bianco, G. Turchetti, M. Mosca, R. Talarico
DOI: https://doi.org/10.55563/clinexprheumatol/1lx7a5
Review
CER13995
2021,39,5,Suppl.132
Pg. 0094-0101
Free to view
Ocular manifestations of Behçet’s disease in children and adults: a systematic review and meta-analysis
M.A. Turk, J.L. Hayworth, T. Nevskaya, J.E. Pope
DOI: https://doi.org/10.55563/clinexprheumatol/pt60bc
M.A. Turk, J.L. Hayworth, T. Nevskaya, J.E. Pope
DOI: https://doi.org/10.55563/clinexprheumatol/pt60bc
Paediatric Rheumatology
CER14202
2021,39,5,Suppl.132
Pg. 0102-0108
Free to view
Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of children
S. Ozen, H.L. Lutz, V.M. Rivera, A. Reiff, E.D. Batu, E. Anderson, M. Salas Garcia, G. Aldrovandi, T.H. Akbaba, İ. Pazarbasi, Y. Bilginer, A. Balat, B. Balci-Peynircioglu, J.A. Gilbert, F. Dedeoglu, J.S. Hausmann
DOI: https://doi.org/10.55563/clinexprheumatol/olvbyd
S. Ozen, H.L. Lutz, V.M. Rivera, A. Reiff, E.D. Batu, E. Anderson, M. Salas Garcia, G. Aldrovandi, T.H. Akbaba, İ. Pazarbasi, Y. Bilginer, A. Balat, B. Balci-Peynircioglu, J.A. Gilbert, F. Dedeoglu, J.S. Hausmann
DOI: https://doi.org/10.55563/clinexprheumatol/olvbyd
CER14548
2021,39,5,Suppl.132
Pg. 0109-0117
Free to view
Inflammation-related differentially expressed common miRNAs in systemic autoinflammatory disorders patients can regulate the clinical course
T.H. Akbaba, Y.Z. Akkaya-Ulum, Z. Tavukcuoglu, Y. Bilginer, S. Ozen, B. Balci-Peynircioglu
DOI: https://doi.org/10.55563/clinexprheumatol/t67tvc
T.H. Akbaba, Y.Z. Akkaya-Ulum, Z. Tavukcuoglu, Y. Bilginer, S. Ozen, B. Balci-Peynircioglu
DOI: https://doi.org/10.55563/clinexprheumatol/t67tvc
CER14623
2021,39,5,Suppl.132
Pg. 0118-0123
Free to view
The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients
B. Sözeri, H.E. Sönmez, Ş.G. Karadağ, E. Bağlan, K. Öztürk, M. Çakan, F. Demir, G. Otar Yener, S. Özdel, N. Aktay Ayaz
DOI: https://doi.org/10.55563/clinexprheumatol/ef5llq
B. Sözeri, H.E. Sönmez, Ş.G. Karadağ, E. Bağlan, K. Öztürk, M. Çakan, F. Demir, G. Otar Yener, S. Özdel, N. Aktay Ayaz
DOI: https://doi.org/10.55563/clinexprheumatol/ef5llq
CER14653
2021,39,5,Suppl.132
Pg. 0124-0128
Free to view
Children with systemic autoinflammatory diseases have multiple, mixed ethnicities that reflect regional ethnic diversity
L.B. Tucker, I. Niemietz, P. Mangat, M. Belen, J. Tekano, D.A. Cabral, J. Guzman, K.M. Houghton, K.A. Morishita, M.O. Chan, A. Human, M. Sundqvist, K.L. Brown
DOI: https://doi.org/10.55563/clinexprheumatol/8cjqiy
L.B. Tucker, I. Niemietz, P. Mangat, M. Belen, J. Tekano, D.A. Cabral, J. Guzman, K.M. Houghton, K.A. Morishita, M.O. Chan, A. Human, M. Sundqvist, K.L. Brown
DOI: https://doi.org/10.55563/clinexprheumatol/8cjqiy
CER14662
2021,39,5,Suppl.132
Pg. 0129-0134
Free to view
The performance of the diagnostic scoring system or criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis for adult-onset Still’s disease. A multicentre case-control study in China
H. Yao, Y. Wang, Z. Wang, J. Zhao, X. Deng, Z. Zhang, Y. Zhao, Y. Zhang, Q. Shu, Y. Jia, Z.-G. Li
DOI: https://doi.org/10.55563/clinexprheumatol/k7ri2l
H. Yao, Y. Wang, Z. Wang, J. Zhao, X. Deng, Z. Zhang, Y. Zhao, Y. Zhang, Q. Shu, Y. Jia, Z.-G. Li
DOI: https://doi.org/10.55563/clinexprheumatol/k7ri2l
Letters to the Editor
CER13984
2021,39,5,Suppl.132
Pg. 0135-0136
Free to view
Occipital neuralgia as a manifestation of neuro-Behçet’s relapse: a case report
Z.E. Kaya Gulec, E. Seyahi, U. Uygunoglu
DOI: https://doi.org/10.55563/clinexprheumatol/6alq5u
Z.E. Kaya Gulec, E. Seyahi, U. Uygunoglu
DOI: https://doi.org/10.55563/clinexprheumatol/6alq5u
CER14763
2021,39,5,Suppl.132
Pg. 0137-0138
Free to view
Histopathology of perforated gastrointestinal tracts in Behçet’s disease: evidence for the critical role of thrombophilia
S. Hirohata, H. Kikuchi, M. Ueda, M. Kyogoku
DOI: https://doi.org/10.55563/clinexprheumatol/p24org
S. Hirohata, H. Kikuchi, M. Ueda, M. Kyogoku
DOI: https://doi.org/10.55563/clinexprheumatol/p24org
CER14985
2021,39,5,Suppl.132
Pg. 0139-0140
Free to view
Flare-up of adult-onset Still’s disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine
S. Yamamoto, K. Nishimura, K. Yo, D. Waki, H. Murabe, T. Yokota
DOI: https://doi.org/10.55563/clinexprheumatol/tvlpnc
S. Yamamoto, K. Nishimura, K. Yo, D. Waki, H. Murabe, T. Yokota
DOI: https://doi.org/10.55563/clinexprheumatol/tvlpnc
CER14824
2021,39,5,Suppl.132
Pg. 0141-0142
Free to view
Cerebral venous thrombosis in a child with Behçet's disease: a complication to bear in mind also in children
I. Maccora, A. Alletto, M. Lo Russo, P. Vasarri, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/9moyyx
I. Maccora, A. Alletto, M. Lo Russo, P. Vasarri, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/9moyyx